MBCOF (Marvel Biosciences) OCF Margin %: 0.00% (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
33 GF Score
Price $0.12
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences OCF Margin %?

Marvel Biosciences MBCOF +4.74% 33 OCF Margin % is 0.00% as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Marvel Biosciences ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Marvel Biosciences's Cash Flow from Operations for the three months ended in Apr. 2026 was $0.12 Mil. Marvel Biosciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, Marvel Biosciences's OCF Margin % for the quarter that ended in Apr. 2026 was 0.00%.

As of today, Marvel Biosciences's current OCF Yield % is -7.78%.

The historical rank and industry rank for Marvel Biosciences's OCF Margin % or its related term are showing as below:


MBCOF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.


Marvel Biosciences OCF Margin % Related Terms


Marvel Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences OCF Margin % Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MBCOF
33GF Score
Marvel Biosciences Corp MBCOF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Marvel Biosciences's OCF Margin for the fiscal year that ended in Jul. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-0.84/0
= %

Marvel Biosciences's OCF Margin for the quarter that ended in Apr. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=0.119/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Marvel Biosciences (MBCOF) has a OCF Margin % of 0.00% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Marvel Biosciences and its competitors. According to the industry distribution chart, Marvel Biosciences ranks #999999 out of 959 companies in the Biotechnology industry.
Is Marvel Biosciences' OCF Margin % too high?
Marvel Biosciences' current OCF Margin % is 0.00%. Based on the distribution chart, Marvel Biosciences ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Marvel Biosciences ranks #999999 out of 959 companies for OCF Margin %. This places Marvel Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current OCF Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score

Get the complete analysis for MBCOF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price